Oculus Innovative Sciences Announces New Regulatory Approvals and Target Launch Dates for Three New Microcyn(R)-Based Products in Middle East Countries Apr 24, 2013
Oculus Innovative Sciences to Rollout Five New Microcyn(R) Technology-Based Products in Singapore and Malaysia Apr 10, 2013
Oculus Innovative Sciences Strengthens Intellectual Property Portfolio With Issuance of Three New International Patents for Microcyn(R) Technology Apr 4, 2013
Oculus Innovative Sciences Expands Regulatory Claims for Microcyn-Based Advanced Wound Management Products in Europe Mar 26, 2013
Oculus Innovative Sciences Announces Completion of Patient Follow-Up in Scar Management Study Mar 14, 2013
Oculus Innovative Sciences Announces Closing of Public Offering of 8,625,000 Shares of Common Stock Mar 12, 2013
Oculus Innovative Sciences, Inc. Announces Full Exercise of Underwriters' Over-Allotment Option Mar 7, 2013
Oculus Innovative Sciences Announces Pricing of Public Offering of 7,500,000 Shares of Common Stock and Intention to Repay Certain Indebtedness Mar 7, 2013
